Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Gefitinib|DRUG: Docetaxel
Sponsor: AstraZeneca